http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E6%85%A2%E6%80%A7%E8%82%BE%E5%B0%8F%E7%90%83%E8%82%BE%E7%82%8E-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-TNF-%CE%B1
慢性肾小球肾炎-实验室检查-TNF-α - 版本历史
2026-05-10T05:40:59Z
本wiki的该页面的版本历史
MediaWiki 1.30.0
http://120.24.161.253:5617/index.php?title=%E6%85%A2%E6%80%A7%E8%82%BE%E5%B0%8F%E7%90%83%E8%82%BE%E7%82%8E-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-TNF-%CE%B1&diff=1272084&oldid=prev
Admin：修改1
2024-07-06T14:00:00Z
<p>修改1</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E6%85%A2%E6%80%A7%E8%82%BE%E5%B0%8F%E7%90%83%E8%82%BE%E7%82%8E-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-TNF-%CE%B1&diff=1272085&oldid=prev
KGadmin：导入1个版本
2024-07-06T09:29:27Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 09:29的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td>
<td colspan="2" class="diff-lineno">第7行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===慢性肾小球肾炎患者血清Lkn-1及TNF-α变化及意义（中华医学会文献）===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===慢性肾小球肾炎患者血清Lkn-1及TNF-α变化及意义（中华医学会文献）===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[慢性肾小球肾炎]]患者血清Lkn-1、[[TNF-α]]水平与硬化肾小球比例呈正相关(r＝0.667、0.672,P<del class="diffchange diffchange-inline"><</del>0.01),[[TNF-α]]水平与24h尿蛋白呈正相关(r=0.348,P<del class="diffchange diffchange-inline"><</del>0.01).</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[慢性肾小球肾炎]]患者血清Lkn-1、[[TNF-α]]水平与硬化肾小球比例呈正相关(r＝0.667、0.672,P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.01),[[TNF-α]]水平与24h尿蛋白呈正相关(r=0.348,P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.01).</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===IL-1及其联合指标在慢性肾小球肾炎诊治中的应用（中华医学会文献）===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===IL-1及其联合指标在慢性肾小球肾炎诊治中的应用（中华医学会文献）===</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13" >第13行：</td>
<td colspan="2" class="diff-lineno">第13行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===慢性肾小球肾炎患者血清凝血酶激活的纤溶抑制物和肿瘤坏死因子的水平变化及临床意义（中华医学会文献）===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===慢性肾小球肾炎患者血清凝血酶激活的纤溶抑制物和肿瘤坏死因子的水平变化及临床意义（中华医学会文献）===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果 [[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平均显著高于健康对照组,差异有显著性(P<del class="diffchange diffchange-inline"><</del>0.01);不同分期[[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平比较,呈尿毒症期<del class="diffchange diffchange-inline">></del>肾衰竭期<del class="diffchange diffchange-inline">></del>肾衰早期的趋势,差异有显著性(P<del class="diffchange diffchange-inline"><</del>0.01);TAFI水平与24 h尿</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果 [[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平均显著高于健康对照组,差异有显著性(P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.01);不同分期[[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平比较,呈尿毒症期<ins class="diffchange diffchange-inline">&amp;gt;</ins>肾衰竭期<ins class="diffchange diffchange-inline">&amp;gt;</ins>肾衰早期的趋势,差异有显著性(P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.01);TAFI水平与24 h尿</div></td></tr>
</table>
KGadmin
http://120.24.161.253:5617/index.php?title=%E6%85%A2%E6%80%A7%E8%82%BE%E5%B0%8F%E7%90%83%E8%82%BE%E7%82%8E-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-TNF-%CE%B1&diff=205157&oldid=prev
Admin：导入1个版本
2021-10-21T07:56:22Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2021年10月21日 (四) 07:56的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E6%85%A2%E6%80%A7%E8%82%BE%E5%B0%8F%E7%90%83%E8%82%BE%E7%82%8E-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-TNF-%CE%B1&diff=205152&oldid=prev
Admin：修改1
2021-10-19T13:56:59Z
<p>修改1</p>
<p><b>新页面</b></p><div>主实体：[[慢性肾小球肾炎]]，关系：[[实验室检查]] ，尾实体：[[TNF-α]]<br />
<br />
实体ID:''439244''<br />
==关系介绍==<br />
待补充<br />
<br />
==来源==<br />
===慢性肾小球肾炎患者血清Lkn-1及TNF-α变化及意义（中华医学会文献）===<br />
[[慢性肾小球肾炎]]患者血清Lkn-1、[[TNF-α]]水平与硬化肾小球比例呈正相关(r＝0.667、0.672,P<0.01),[[TNF-α]]水平与24h尿蛋白呈正相关(r=0.348,P<0.01).<br />
<br />
===IL-1及其联合指标在慢性肾小球肾炎诊治中的应用（中华医学会文献）===<br />
目的 探讨IL-1、[[TNF-α]]等指标在不同类型[[慢性肾小球肾炎]]发病过程中的作用.<br />
<br />
===慢性肾小球肾炎患者血清凝血酶激活的纤溶抑制物和肿瘤坏死因子的水平变化及临床意义（中华医学会文献）===<br />
结果 [[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平均显著高于健康对照组,差异有显著性(P<0.01);不同分期[[慢性肾小球肾炎]]患者血清TAFI和[[TNF-α]]水平比较,呈尿毒症期>肾衰竭期>肾衰早期的趋势,差异有显著性(P<0.01);TAFI水平与24 h尿</div>
Admin